Boostrix
Tetanus Toxoid, Reduced Diphtheria Toxoid and Acellular Pertussis Vaccine, Adsorbed · Suspension · Intramuscular
No FDA structured label text is available for Boostrix. The NDC listings below come from the FDA National Drug Code directory.
Active ingredients
- Clostridium Tetani Toxoid Antigen (formaldehyde Inactivated) in 2 products
- Corynebacterium Diphtheriae Toxoid Antigen (formaldehyde Inactivated) in 2 products
- Bordetella Pertussis Toxoid Antigen (formaldehyde, Glutaraldehyde Inactivated) in 2 products
- Bordetella Pertussis Filamentous Hemagglutinin Antigen (formaldehyde Inactivated) in 2 products
- Bordetella Pertussis Pertactin Antigen (formaldehyde Inactivated) in 2 products
Boostrix NDC products (2)
| NDC | Strength & form | Labeler | Type |
|---|---|---|---|
| 50090-1377 | Clostridium Tetani Toxoid Antigen (formaldehyde Inactivated) 5 [iU]/.5mL; Corynebacterium Diphtheriae Toxoid Antigen… Suspension | A-S Medication Solutions | BLA |
| 58160-842 | Clostridium Tetani Toxoid Antigen (formaldehyde Inactivated) 5 [iU]/.5mL; Corynebacterium Diphtheriae Toxoid Antigen… Suspension | GlaxoSmithKline Biologicals SA | BLA |
Frequently asked questions
Who makes Boostrix?
Boostrix is listed by 2 labelers in the FDA NDC directory, including A-S Medication Solutions, GlaxoSmithKline Biologicals SA.